Bioinspired NiCoO₂ nanocomposites derived from Moringa oleifera as a recyclable catalyst for the synthesis of pyrazolopyrano[2,3-d]pyrimidine with potent antimicrobial efficiency.

Authors

Prakash Kokare, Avdhut Kadam, Ashwini More, Vijay Shinde, Vishvanath Ghanwat, Nilesh Pandit, Chaitali Bagade, Avinash Survase, Komal Mali, Santosh Kamble

Published in

Discover nano. Volume 21. Issue 1. Aug 03, 2026. Epub Aug 03, 2026.

Abstract

A green synthetic approach was developed for the preparation of a NiCoO₂ nanocomposite using an aqueous extract of Moringa oleifera as both a reducing and stabilizing agent. The synthesized NiCoO₂ nanocomposite exhibited high crystallinity and measurable antimicrobial activity. Detailed characterization using XRD, UV-visible spectroscopy, fluorescence spectroscopy, FTIR, BET, SEM, EDS, elemental mapping, and TEM analyses confirmed its crystalline structure, elemental composition, thermal stability, surface functional groups, and morphological features. The nanocomposite and the synthesized products were evaluated for antimicrobial activity against S. aureus, B. cereus, P. vulgaris, and S. typhimurium, demonstrating inhibitory effects against the tested microorganisms. The NiCoO₂ nanocomposite was also employed as a heterogeneous catalyst in a one-pot multicomponent condensation reaction of aldehydes, hydrazine hydrate, barbituric acid, and ethyl acetoacetate under ultrasonic conditions, affording pyrazolopyrano[2,3-d]pyrimidine derivatives in yields of up to 98% within short reaction times. The catalyst retained its activity over five consecutive cycles, indicating good recyclability. Furthermore, the synthesized heterocycles exhibited antimicrobial activity against both Gram-positive and Gram-negative bacterial strains. Molecular docking studies revealed that all synthesized compounds (1-11) exhibited favorable binding affinities toward the 4COX enzyme, with docking scores higher than that of the reference drug indomethacin, suggesting their potential for further biological evaluation.

PMID:
42545597
Bibliographic data and abstract were imported from PubMed on 03 Aug 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.